MDCX (STOCKS)
Medicus Pharma Ltd. Common Stock
$0.993200
+0.043200 (+4.55%)
Prev close: $0.950000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Raza Bokhari
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.81M
- Employees
- 12
- P/E (TTM)
- -0.47
- P/B (TTM)
- -22.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.65 | $-0.30 | -0.3542 | -119.74% |
|
Jun 2025 (Q2)
|
$-0.42 | $-0.26 | -0.1582 | -60.43% |
|
Mar 2025 (Q1)
|
$-0.42 | $-0.24 | -0.1820 | -76.47% |
|
Dec 2024 (Q4)
|
$-0.18 | $-0.30 | +0.1158 | +39.15% |
Financial Statements
| Revenues | $75.09K |
| Operating Expenses | $14.73M |
| Research and Development | $6.50M |
| Other Operating Expenses | $23.66M |
| Operating Income/Loss | -$14.73M |
| Income/Loss From Continuing Operations After Tax | -$30.80M |
| Income/Loss From Continuing Operations Before Tax | -$30.80M |
| Net Income/Loss | -$30.80M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$77.00 |
| Net Income/Loss Attributable To Parent | -$35.75M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.75M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $77.00 |
| Preferred Stock Dividends And Other Adjustments | $77.00 |
| Basic Earnings Per Share | -$2.29 |
| Diluted Earnings Per Share | -$2.29 |
| Basic Average Shares | 45,738,397 |
| Diluted Average Shares | 45,738,397 |
| Assets | $9.98M |
| Current Assets | $9.78M |
| Prepaid Expenses | $1.12M |
| Other Current Assets | $8.66M |
| Noncurrent Assets | $196.25K |
| Liabilities | $10.78M |
| Current Liabilities | $10.66M |
| Accounts Payable | $2.03M |
| Wages | $297.30K |
| Other Current Liabilities | $8.33M |
| Noncurrent Liabilities | $124.65K |
| Equity | -$804.89K |
| Equity Attributable To Noncontrolling Interest | $105.24K |
| Equity Attributable To Parent | -$910.13K |
| Liabilities And Equity | $9.98M |
| Net Cash Flow From Operating Activities | -$19.36M |
| Net Cash Flow From Operating Activities, Continuing | -$19.36M |
| Net Cash Flow From Investing Activities | -$3.48M |
| Net Cash Flow From Investing Activities, Continuing | -$3.48M |
| Net Cash Flow From Financing Activities | $27.34M |
| Net Cash Flow From Financing Activities, Continuing | $27.34M |
| Net Cash Flow | $4.50M |
| Net Cash Flow, Continuing | $4.50M |
| Comprehensive Income/Loss | -$35.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $75.00 |
| Comprehensive Income/Loss Attributable To Parent | -$35.74M |
| Other Comprehensive Income/Loss | -$4.94M |